Japan has become the first country to approve Ronapreve antibody treatment to cure covid-19. Japan’s ministry of health, labor, and welfare approved the Ronapreve antibody after a test consisting of 3 phrases. This antibody is produced by the corporation of US biotech firm Regeneron. Tests showed that Ronapreve reduced mild or moderate COVID-19 illness.
